Colony stimulating factors as adjunctive therapy in neonatal sepsis

Indian Journal of Pediatrics

Volumn 73, Issue 5, 2006, Pages 393-394

  Gathwala, Geeta ^a   Bala, Harsh ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOLOGIC FACTOR;

BONE MARROW; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; HUMAN; NEUTROPENIA; NEUTROPHIL; SEPSIS; THROMBOCYTOPENIA; IMMUNOLOGY; NEWBORN;

COLONY-STIMULATING FACTORS; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; NEUTROPENIA; SEPSIS;

EID: 33746771444     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02758558     Document Type: Editorial

References (18)

1. Banerjee MC, Speer CP. The current role of colony stimulating factors in prevention and treatment of neonatal sepsis. Semin Neonatol 2002; 7 : 335-349.
2. Cairo MS. Cytokines: A new immunotherapy. Clinics in Perinatol 1991; 81 : 343-355.
3. Cairo MS, Ellis R. Results of phase I/II trial of rhGM_CSF in VLBW neonates; significant induction of circulating neutrophils,monocytes, platelets and bone marrow neutrophils. Blood 1995; 86 : 2509-2515.
4. Rodwell RL, Taylor K. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infectious Dis J 1993; 12 : 372-376.
5. Schibler KR, White WL. Production of G-CSF in vitro by monocytes from preterm and term neonates. Blood 82: 2478-2484.
6. Roberts RL, Szelc CM, Scates SM . Neutropenia in an extremely premature infant treated with rhG-CSF. Am J Dis Child 1991; 145 : 803-812.
7. Gillan ER, Christensen RD, Suen YU, Elis R, deVen CV, Cario SM. A randomized placebo controlled trial of rhG-CSF administration in newborn infants with presumed sepsis : significant induction of peripheral and bone marrow neutrophilia. Blood 1994; 84 : 1427-1433.
8. Barak Y, Leibovitz E, Mogilner B, Amitay M, Bullin A, Koren A. The in vivo effect of recombinant human G_CSF in neutropenic neonates with sepsis. Eur J Pediatr 1997; 156 : 643-646.
9. Kocherlakota P, La Gamma E. Human G-CSF may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 1997; 100 : 6-8.
10. Kocherlakota P, La Gamma EF. Preliminary report: rhGCSF may reduce the incidence of neonatal sepsis in prolonged pre eclampsia associated neutropenia. Pediatrics 1998; 102 : 1107-1111.
11. Russel B, Emmerson N, Wilkinson N, Chant T, Sweet DG, Halliday HL. A trial ofsrhG-CSF for the treatment of VLBW infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed 2001; 84: F7 2-6.
12. Drossou AV, Kanakoudi T, Kremenopoulous G. Administration of rhG_CSF to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and b2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr 1998; 157 : 583-588.
13. Bilgin K,Yarami A,Haspolat K, Alitas M,Gunbey S,Derman O. A randomized trial of GM-CSF in neonates with sepsis and neutropenia. Pediatrics 2001; 107 : 36-41.
14. Ahmad A, LaboradaG, Bussel J, NesinM. Comparision of rh-GCSF and placebo for treatment of septic preterm infants. Pediatr Infect Dis J 2002; 21 : 1061-1065.
15. Miura E, Procianoy RS, Miura CS, Miura MS, Mello C, Christensen RD. A randomized, double masked, placebo controlled trial of rG-CSF administration to preterm infants with the clinical diagnosis of early onset sepsis. Pediatrics 2001; 107 : 30-35.
16. Bernstein HM, Poolock BH, Calboun DA, Christemen RD. Administration of G-CSF to neonates with septicaemia: A metaanalysis. J Pediatr 2001; 138 : 917-920.
17. Russel B, Davis EG. rhG-CSF treatment for neonatal neutropenia. Arch Dis Child 1995; F53-4.
18. Rosenthal MD, Healy MS, Gillina E. Astwo years follow up of neonates with presumed sepsis treated with rhG-CSF factor during the first week of life. J Pediatr 1996; 128 : 135-1357.